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ABSTRACT: A new withanolide, named withawrightolide (1), and four known
withanolides (2−5) were isolated from the aerial parts of Datura wrightii. The
structure of compound 1 was elucidated through 2D NMR and other
spectroscopic techniques. In addition, the structure of withametelin L (2) was
confirmed by X-ray crystallographic analysis. Using MTS viability assays,
withanolides 1−5 showed antiproliferative activities against human glioblastoma
(U251 and U87), head and neck squamous cell carcinoma (MDA-1986), and
normal fetal lung fibroblast (MRC-5) cells with IC50 values in the range between
0.56 and 5.6 μM.
Withanolides are a group of modified, highly oxygenatedC28 ergostane-type steroids, present primarily in several
genera of the Solanaceae, which include Acnistus, Datura,
Dunalia, Jaborosa, Physalis, and Withania. In recent years these
compounds have gained significant scientific interest due to
their structural and biological diversity, in conjunction with
their antitumor capacities.1−3 Recently we reported, as part of
an ongoing study, the isolation and antiproliferative activities of
a series of withanolides from Physalis longifolia, Vassobia
brevifolia, and Withania somnifera with oxygenation at C-1, 3,
4, 5, 6, 7, 11, 17, 19, 20, 22, 27, and 28.4−7
The Datura genus is a rich source of oxygen-substituted C-21
withanolides,2 yet there have been limited biological activity
studies. We therefore chose to investigate the native Kansas
plant Datura wrightii Regel to continue our Solanaceae-derived
withanolide work and to further probe withanolide structure−
activity relationships.3,4
We report herein the first phytochemical and bioactivity
study of withanolides from D. wrightii including all details
pertaining to the isolation, structure elucidation, and cytotox-
icity (using MTS viability assays) of the new withanolide
withawrightolide (1) and four known withanolides (2−5).
Compounds 1−5 were isolated from a CH2Cl2−MeOH
(1:1) extract of the aerial parts of the title plant (see
Experimental Section). The molecular formula of the minor
component 1 was determined to be C28H38O5 by HRESIMS
and NMR experiments, equating to 10 double-bond equiv-
alents. The IR absorptions of 1 indicated the presence of OH
(3435 cm−1) and keto and ester (1740 and 1705 cm−1) groups.
The 1H NMR spectrum (Table 1) showed signals of three
methyl groups at δ 0.72 (3H, s), 1.12 (3H, s), and 1.42 (3H, s);
four protons attached to oxygenated carbons at δ 3.31 (1H, t, J
= 2.9 Hz), 3.71 (1H, dd, J = 3.3, 13.3 Hz), 3.87 (1H, d, J = 13.3
Hz), and 4.64 (1H, brs); and two olefinic methine groups at δ
6.00 (1H, s) and 6.75 (1H, s). The 13C NMR (APT) and
HSQC spectra for 1 (Table 1) displayed 28 carbon signals
differentiated as three CH3, 10 CH2 (including an olefinic at δ
130.3 and an oxygenated at δ 60.7), eight CH (including two
oxygenated at δ 75.7 and 73.1), and seven C (including a keto
carbonyl at δ 217.7, an ester carbonyl at δ 165.4, an olefinic at δ
139.0, and an oxygenated at δ 69.5), corresponding to C28H37.
The remaining hydrogen atom was therefore assigned as an OH
group, indicating that seven rings must be present in the
structure.
The NMR data of 1 were closely related to a major isolate of
our investigation, the six-ringed withanolide withametelin L (2)
[(20R ,22R ,24R)-21,24-epoxy-12β-hydroxy-1-oxowitha-
2,25,25(27)-trienolide].8 The structure of 2 was confirmed by
X-ray crystallographic studies as shown in Figure 1.
Compounds 1 and 2 were found to contain identical bicyclic
side chain moieties; an exocyclic double bond [an olefinic
methylene C-27 at δC 130.3 and two singlet olefinic protons at
δH 6.00 and 6.75 (each 1H, s, H2-27)] conjugated with the
lactone carbonyl (C-26: δC 165.4); characteristic signals for
oxygenated C-21 [a methylene with δC 60.7 and two protons at
δH 3.87 (1H, d, J = 13.3 Hz), 3.71 (1H, dd, J = 13.3, 3.3 Hz)]
and C-22 [a methine with δC 75.7 and δH 4.64 (1H, brs)]; and
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a tertiary methyl group C-28 with δC 25.9 and δH 1.42 (3H, s)
adjacent to the oxygenated quaternary C-24 with δC 69.5.
The differences between 1 and 2 were observed within the
steroid nucleus moieties. Compound 1 showed unusual NMR
signals for a keto group (δ 217.7) and a methylene group [δC
17.2, δH 0.78 (1H, ddd, J = 1.7, 5.8, 5.9 Hz) and 0.065 (1H, dd,
J = 3.8, 5.8 Hz)], implying the presence of a five-membered
keto ring (the chemical shift value of a keto group in a six-
membered ring is less than 210 ppm) and a cyclopropane ring
(when considering the markedly low chemical shift value at δH
0.065 and small geminal coupling constant 5.8 Hz),
respectively. The presence of 1-oxo-3,5-cyclo-6-hydroxy in the
A/B rings of the steroid nucleus was deduced by HSQC and
1H−1H COSY fragment of −C(2)H2−C(3)H−C(4)H2− and
HMBC correlations between H3-19 (δ 1.12, 3H, s) and C-1 (δ
217.7), C-5 (δ 36.0), C-9 (δ 47.4), and C-10 (δ 52.6) and
between H-3 (δ 1.39, 1H, m) and C-1, C-5, and C-6 (δ 73.1).
The presence of a three-membered ring formed by C-3, C-4,
and C-5 was also supported by the chemical shift values of C-3
(CH, δ 16.0), C-4 (CH2, δ 17.2), and C-5 (C, δ 36.0). Thus,
the planar structure of 1 was represented as shown.
As for the stereochemistry, β orientation of the H-3 proton
was assigned based on the ROESY correlation between H-3 and
H3-19. Axial β orientation of the OH group at C-6 was
established by the small coupling constant between H-6 (δ
3.31, t, J = 2.9 Hz) and H2-7 and the ROESY correlation
between H-6 and H-4α (δ 0.78, 1H, ddd, J = 1.7, 5.8, 5.9 Hz).
These NMR data and assignments were in good agreement
with those withanolides reported in the literature with a 1-oxo-
3,5-cyclo-6-hydroxy functionality in the A/B rings of the steroid
nucleus.9,10 Accordingly, the structure of 1 was elucidated as
(20R,22R,24R)-21,24-epoxy-3α,5α-cyclo-1-oxowitha-25(27)-
enolide on the basis of biogenetic grounds and subsequently
named withawrightolide. Detailed 1H and 13C NMR spectro-
metric analyses utilizing 2D correlational techniques were
undertaken and are summarized in Table 1.
The four other withanolides were identified through data
comparisons with those published in the literature, as
withametelin L (2),8 withametelin, also known as daturilin
(3),11,12 withametelin O (4),8 and withametelin F (5).13
Withawrightolide (1) contains a cyclopropane ring, a rarity in
withanolides. A literature investigation showed that only five of
the 820 withanolides reported to date contain a cyclopropane
ring: physalin S isolated from Physalis alkekengi var. f rancheti;9
cilistols p, pm, p1, and u from Solanum cilistum (Solanaceae).10
This is the first report of such a structural type3 present in
Datura species.
All the five withanolides (1−5) isolated were tested for
cytotoxicity against human glioblastoma (U251 and U87), head
and neck squamous cell carcinoma (MDA-1986), and normal
fetal lung fibroblast (MRC-5) cells, the results of which are
summarized in Table 2. Withanolides 1−5 demonstrated
cytotoxicity with IC50 values ranging from 0.56 to 3.6 μM in
Table 1. 1H (500 MHz) and 13C (125 MHz) NMR Data for Withawrightolide 1 in CDCl3
position δC, type δH (J in Hz) position δC, type δH (J in Hz)
1 217.7, C 15 24.1, CH2 1.73, m; 1.26, m
2 39.6, CH2 2.81, ddd (1.7, 5.4, 18.1); 2.14, d (18.1) 16 26.7, CH2 1.74, m; 1.42, m
3 16.0, CH 1.39, m 17 47.7, CH 1.75, m
4 17.2, CH2 0.065, dd (3.8, 5.8); 0.78, ddd (1.7, 5.8, 5.9) 18 13.0, CH3 0.72, s
5 36.0, C 19 15.0, CH3 1.12, s
6 73.1, CH 3.31, t (2.9) 20 39.8, CH 1.84, m
7 37.4, CH2 1.96, m; 1.27, m 21 60.7, CH2 3.87, d (13.3); 3.71, dd (3.3, 13.3)
8 29.3, CH 1.86, m 22 75.7, CH 4.64, brs
9 47.4, CH 0.97, ddd (3.4, 10.7, 12.2) 23 33.5, CH2 2.0, dd (1.7, 9.0); 1.90, m
10 52.6, C 24 69.5, C
11 22.2, CH2 1.42, m; 1.34, m 25 139.0, C
12 39.5, CH2 1.89, m; 1.31, m 26 165.4, C
13 43.3, C 27 130.3, CH2 6.75, s; 6.00, s
14 55.8, CH 1.15, m 28 25.9. CH3 1.42, s
Figure 1. X-ray ORTEP drawing of withametelin L (2).
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the cancer cells and 3.3−5.6 μM in the normal fibroblasts.
Specifically, concentrations required to obtain cytotoxicity in
the normal MRC-5 cells were 3.8−7.4-fold higher than those in
U87 cells. Our previously published work on a commonly
known withanolide, withaferin A,4,13 is provided as a control for
comparison. The potencies of 1−5 are on average slightly lower
than withaferin A, suggesting that oxygenation of C-21 did not
contribute toward the observed antiproliferative activities.
Furthermore, the comparison of withanolides 2 (12β-hydroxy
3) and 3 revealed that oxygenation of C-12 is also not a
contributor for antiproliferative activities. These observations
are in good agreement with those reported in the literature.3
On the other hand, withanolides 1−5 appear to have greater
selectivity than withaferin A for cancer cells (especially in the
glioma and head and neck squamous cancer cells tested)
compared to normal cells such as fibroblasts with average
selectivity of between 4- and 7-fold. Such a level of selectivity
may provide for a larger therapeutic window for treatment in
vivo.
Due to the observed proliferation inhibition of the
withanolides 1−5, further U251cell-based Western blot analysis
was performed. Total cell expression of heat shock protein 70
(HSP70) and HSP32, proteins associated with cellular stress
and withaferin A activity,13 was monitored 24 h post-treatment
(Figure 2). Post-treatment HSP70 upregulation was observed
for 5 μM concentrations of withanolides 2, 3, and 5.
Withanolides 1−5 elevated HSP32 levels in a concentration-
dependent manner.
In this report, the heat shock effect and oxidative stress effect
were abrogated following administration of N-acetylcysteine to
the cells. This stress response effect was observed only with
compounds 2, 3, and 5. It is likely that the epoxide at C5−C6
in compound 5 may lead to free radical or reactive-oxygen
species formation, which could explain an oxidative stress on
the cells. Additionally the double bond at C5−C6 (compounds
2 and 3) may also convey some of the biologic activity seen
with these molecules, as compounds 1 and 4 lack either an
epoxy group or a double bond at C5−C6 and do not exhibit
this stress response following treatment. Further studies,
however, are warranted to validate this observation and more
completely evaluate the mechanism of antiproliferative action
of these withanolides.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
measured with a Rudolph RS Autopol IV automatic polarimeter. IR
data were obtained with a Thermo Nicolet Avatar 360 FT-IR
spectrometer. NMR spectra were recorded with a Bruker AV-400 or
AV-500 instrument with a cryoprobe for 1H, APT, COSY/DQF-
COSY, HSQC, HMBC, and NOESY/ROESY. Chemical shift values
are given in δ (ppm) using the peak signals of the solvent CDCl3 (δH
7.26 and δC 77.23) as references, and coupling constants are reported
in Hz. ESIMS data were measured with an Agilent 1200 Series LC-
MS/MS ion trap 6300 mass spectrometer. HRESIMS data were
collected with a LCT Premier time-of-flight mass spectrometer
(Waters Corp., Milford, MA, USA). Column chromatography was
performed on silica gel (particle size 12−25 μm) (Sorbent
Technologies, Atlanta, GA, USA), MCI CHP20P (particle size 75−
150 μm) (Sigma-Aldrich, St. Louis, MO, USA), Sephadex LH-20 (GE
Healthcare, Piscataway, NJ, USA), or C18 reversed-phase silica gel
(particle size 40−65 μm) (Sigma-Aldrich). Normal-phase silica gel G
TLC plates (w/UV 254) and reversed-phase C18 TLC plates (w/UV
254) (Sorbent Technologies) were used for fraction and compound
detection. The spots were visualized using UV light at 254 nm and
spraying with 10% EtOH−sulfuric acid reagent. Semipreparative
HPLC was performed on an Agilent 1200 unit equipped with a DAD
detector, utilizing a Lichrospher RP-18 column (250 × 10 mm, 5 μm).
Plant Material. The fresh aerial parts of D. wrightii were collected
in July 2010 from the Quivira National Wildlife Refuge (latitude:
38.10165°; longitude: 98.45496°), Stafford County, Kansas, and
authenticated by Dr. Kelly Kindscher of the Kansas Biological Survey,
University of Kansas, Lawrence, Kansas, United States. A voucher
specimen, 4091, was deposited in the R.L. McGregor Herbarium of the
University of Kansas.
Extraction and Isolation. The collected biomass was air-dried,
ground to a coarse powder (2.1 kg), and extracted three times with
CH2Cl2−MeOH (50:50, 6.0 L) at room temperature. After removing
the solvents under vacuum, the extract (220 g) was suspended in 400
mL of H2O, followed by successive partitions with n-hexane, ethyl
acetate, and n-butanol (3 × 500 mL). The resulting n-BuOH fraction
(52 g) collected was applied to a MCI CHP20P column (2.0 kg) and
eluted subsequently with mixtures of H2O−MeOH (100:0, 80:20,
60:40, 40:60, 85:15, 0:100), in order of increasing concentrations of
MeOH. The 85% MeOH fraction (12.0 g) was subjected to silica gel
CC, eluted with CH2Cl2−CH3COCH3 with increasing amounts of
acetone, to afford compounds withametelin L (2) (340 mg),
Table 2. Cytotoxicity (IC50) of Isolated Withanolides (μM)
against Four Cell Linesa
compound U87 U251 MDA-1986 MRC-5 MRC-5:U87
1 1.5 3.6 3.1 5.6 3.8
2 0.57 1.3 2.3 4.2 7.4
3 1.0 2.2 2.7 5.1 5.1
4 1.1 2.8 3.0 4.6 4.1
5 0.56 1.4 1.5 3.3 6.0
withaferin Ab 1.1 0.69 0.80 0.20 0.19
aFor cell lines used, see text. bWithaferin A was used as control.
Figure 2. Western blot analysis of glioblastoma cell line U251 following treatment with withanolides 1−5. Total levels of HSP32 and HSP70,
biomarkers of cellular stress and withanolide activity, were screened at 0, 0.1, 0.5, 1, and 5 μM concentrations of each compound for 24 h. HSP70
was markedly upregulated at 5 μM with withanolides 2, 3, and 5, while HSP32 levels were elevated in a concentration-dependent manner with all
compounds 1−5 tested. The β-actin protein was used as a loading control marker.
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withametelin, also known as daturilin (3) (150 mg), withametelin O
(4) (12 mg), and withametelin F (5) (7 mg). The fractions eluted by
CH2Cl2−CH3COCH3 (6:1) were subjected to semipreparative HPLC,
with the mobile phase CH3CN−H2O (44:56), to afford 1 (8 mg).
Withawrightolide (1): amorphous powder; [α]25D +19.2 (c 0.18,
CHCl3); UV (MeOH) λmax (log ε) 226 (3.05) nm; IR (neat) νmax
3435 (br), 2922, 1740, 1705 cm−1; 1H NMR and 13C NMR, see Table
1; ESIMS (positive-ion mode) m/z 455 [M + H]+; HRESIMS m/z
477.2610 [M + Na]+ (calcd for C28H38O5Na, 477.2617).
Single-Crystal X-ray Structure Determination of With-
ametelin L (2). Crystal analysis was performed with a colorless
cubic crystal (dimensions 0.48 × 0.12 × 0.05 mm3) obtained from
CH2Cl2−CH3CN (1:1) using Cu Kα radiation (λ = 1.54178 Å) on a
Bruker APEX2 diffractometer equipped with a Bruker MicroStar
microfocus rotating anode X-ray source and Helios multilayer optics.
Crystal data for 2: C28H36O5 (formula weight 452.57), monoclinic,
space group P21, T = 100(2) K, crystal cell parameters a = 11.7590(3)
Å, b = 6.5766(2) Å, c = 15.0921(4) Å, β = 96.0790(10)°, V =
1160.57(10) Å3, Dc = 1.295 Mg/m
3, Z = 2, F(000) = 488, absorption
coefficient μ = 0.700 mm−1. A total of 10 166 reflections were
collected in the range 2.94° < θ < 69.26°, with 2971 independent
reflections [R(int) = 0.0155]; completeness to θ = 66° was 96.5%.
Multiscan absorption correction applied; full-matrix least-squares
refinement on F2; the number of data/restraints/parameters were
2971/1/443; goodness-of-fit on F2 = 1.060; final R indices [I > 2σ(I)],
R1 = 0.0249, wR2 = 0.0646; R indices (all data), R1 = 0.0249, wR2 =
0.0646; largest difference peak and hole, 0.169 and −0.126 e/Å−3.
Cell Culture and Cell Proliferation and Viability Assay. Two
human glioblastoma cell lines, U251 and U87, were generously
provided by Dr. Jann Sarkaria (Mayo Clinic, Rochester, MN, USA).
The head and neck squamous cell carcinoma (HNSCC) cell line
MDA-1986 was a gift from Dr. Jeffrey Myers (University of Texas,
M.D. Anderson Cancer Center, Houston, TX, USA). The fetal lung
fibroblast cell line MRC-5 was obtained from ATCC. Cell
maintenance, experimental procedures, and data presentation were
similar to those previously described.4,14 The U87 and U251 cell lines
were grown in DMEM (#6429; Sigma-Aldrich) supplemented with
10% fetal bovine serum (Sigma-Aldrich) and 1% penicillin/
streptomycin (100 IU/mL/100 μg/mL; Sigma-Aldrich). The MDA-
1986 and MRC-5 cell lines were grown in similar media but also
supplemented with 1% L-glutamine (200 mM; Sigma-Aldrich), 1%
MEM-vitamin (100×; Hyclone, Logan, UT, USA), and 1% MEM-
nonessential amino acids (Sigma Aldrich). The cells were grown in a
monolayer and were incubated at 37 °C in a humidified atmosphere
containing 5% CO2 until they reached 75−90% confluence. The
viability of cells after treatment with withanolides (1−5) was
determined using an MTS assay. Cells were seeded in 96-well plates
at 2500 cells/well in 90 μL of media. Following an approximate 6 h
incubation period, 10 μL of drug-containing media in various
concentrations was added to each well, and the cells were incubated
for an additional 72 h. The number of viable cells was quantified by the
colorometric CellTiter96 Aqueous MTS assay (Promega, Fitchburg,
WI, USA) at 490 nm on a BioTek Synergy 2 plate reader (BioTek,
Winooski, VT, USA) as per the manufacturer’s instructions. All
experiments were carried out in triplicate on two separate occasions,
and GraphPad (GraphPad Inc., San Diego, CA, USA) was used to
generate best-fit sigmoidal dose−response curves for IC50 determi-
nation.
Western Blotting Analysis. Cells were plated at an amount
previously determined, based on the growth characteristics of the cells,
to have a high enough yield without achieving complete confluency
upon harvest and were allowed to grow overnight. Cells were treated
with appropriate concentrations of the withanolides. Upon completion
of treatment, proteins were collected, quantified, separated by sodium
dodecyl sulfate−polyacrylamide gel electrophoresis (SDS-PAGE), and
electrotransfered onto a Hybond nitrocellulose membrane as
previously described.4 Actin levels were assessed to ensure equal
loading and transfer of proteins. Western analysis was completed in
the human U251 cell line. Primary antibodies were utilized against
HSP70 (Enzo Life Sciences, Farmingdale, NY, USA; ADI-SPA-810;
1:1000), HSP32/heme oxygenase 1 (Enzo Life Sciences; SPA-894;
1:1000), and total actin (EMD Millipore, Billerica, MA, USA;
MAB1501; 1:50 000). Donkey anti-rabbit IgG HRP (sc-2313;
1:5000) and goat anti-mouse IgG HRP (sc-2005; 1:5000) secondary




1H and 13C NMR spectra of withanolide 1 are available free of
charge via the Internet at http://pubs.acs.org. Crystallographic
data for the structure of 2 as reported in this paper were
deposited with the Cambridge Crystallographic Data Centre,
under reference number CCDC 907707. Copies of the data can
be obtained, free of charge, on application to the Director,
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-
(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk).
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